Literature DB >> 31524288

Requirement of activating transcription factor 5 for murine fetal liver erythropoiesis.

Shuping Zhang1, Jane-Jane Chen1.   

Abstract

Activating transcription factor 5 (ATF5) is necessary for the development of various tissues, particularly under stress. Dysfunctions of ATF5 have been shown to be involved in many diseases. The exact function of ATF5 is tissue-specific, and its role in erythropoiesis is still unknown. We here employed the loss of function strategy to investigate the role of ATF5 in murine erythropoiesis. We found that knockdown of Atf5 impaired the proliferation of fetal liver erythroid progenitors. Furthermore, erythroid differentiation was inhibited by ATF5 deficiency. Our study suggests that ATF5 may be a potential therapeutic target for treating blood diseases with ineffective erythropoiesis.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  activating transcription factor 5; differentiation; erythropoiesis; fetal liver; proliferation

Year:  2019        PMID: 31524288     DOI: 10.1111/bjh.16202

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival.

Authors:  Pameila Paerhati; Jing Liu; Zhedong Jin; Tanja Jakoš; Shunyin Zhu; Lan Qian; Jianwei Zhu; Yunsheng Yuan
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 2.  Translational control by heme-regulated elF2α kinase during erythropoiesis.

Authors:  Jane-Jane Chen; Shuping Zhang
Journal:  Curr Opin Hematol       Date:  2022-01-21       Impact factor: 3.218

3.  Loss of the mitochondrial phosphate carrier SLC25A3 induces remodeling of the cardiac mitochondrial protein acylome.

Authors:  Jessica N Peoples; Nasab Ghazal; Duc M Duong; Katherine R Hardin; Janet R Manning; Nicholas T Seyfried; Victor Faundez; Jennifer Q Kwong
Journal:  Am J Physiol Cell Physiol       Date:  2021-07-28       Impact factor: 5.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.